We are live on
!
Find out more
AC
AXQ Capital Portfolio holdings
AUM
$777M
1-Year Est. Return
9.87%
This Fund
S&P 500
This Quarter
Est. Return
+8.2%
1 Year Est. Return
+9.87%
3 Year Est. Return
+23.94%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$310M
AUM Growth
+$60.3M
(+24%)
Cap. Flow
+$49M
Cap. Flow
% of AUM
15.81%
Top 10 Holdings %
Top 10 Hldgs %
7.4%
Holding
817
New
340
Increased
127
Reduced
80
Closed
270
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$2.34M |
| 2 |
PG&E
PCG
|
+$2.05M |
| 3 |
GoDaddy
GDDY
|
+$2.02M |
| 4 |
Constellation Brands
STZ
|
+$1.93M |
| 5 |
Robert Half
RHI
|
+$1.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextEra Energy
NEE
|
+$2.51M |
| 2 |
Salesforce
CRM
|
+$2.17M |
| 3 |
CSX Corp
CSX
|
+$1.98M |
| 4 |
Dollar Tree
DLTR
|
+$1.79M |
| 5 |
Martin Marietta Materials
MLM
|
+$1.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.82% |
| 2 | Industrials | 15.73% |
| 3 | Financials | 15.52% |
| 4 | Consumer Discretionary | 13.8% |
| 5 | Healthcare | 11.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Vaxcyte
PCVX
$8.08B
| $285K | 0.09% |
+8,754
| New | +$287K |
|
377
Intellia Therapeutics
NTLA
$1.55B
| $285K | 0.09% |
+30,335
| New | +$249K |
|
|
AVNS
378
DELISTED
Avanos Medical
AVNS
| $284K | 0.09% |
23,220
-1,432
| -6% | -$18K |
|
379
BlackSky Technology
BKSY
$919M
| $284K | 0.09% |
+13,807
| New | +$149K |
|
380
Revolution Medicines
RVMD
$40.9B
| $282K | 0.09% |
+7,658
| New | +$294K |
|
381
Cognizant
CTSH
$24.3B
| $281K | 0.09% |
+3,602
| New | +$276K |
|
382
Landstar System
LSTR
$5.75B
| $281K | 0.09% |
+2,021
| New | +$280K |
|
383
Moderna
MRNA
$23B
| $279K | 0.09% |
+10,099
| New | +$266K |
|
384
ArriVent BioPharma
AVBP
$1.43B
| $277K | 0.09% |
+12,735
| New | +$264K |
|
385
Seagate
STX
$193B
| $277K | 0.09% |
+1,918
| New | +$199K |
|
|
GMS
386
DELISTED
GMS Inc
GMS
| $274K | 0.09% |
+2,520
| New | +$195K |
|
387
Brown & Brown
BRO
$23.7B
| $274K | 0.09% |
+2,469
| New | +$277K |
|
|
P
388
Everpure Inc
P
$25B
| $273K | 0.09% |
+4,742
| New | +$236K |
|
389
Spectrum Brands
SPB
$2.04B
| $273K | 0.09% |
5,143
-2,711
| -35% | -$162K |
|
390
United States Lime & Minerals
USLM
$3.24B
| $273K | 0.09% |
+2,731
| New | +$267K |
|
391
Caesars Entertainment
CZR
$6.03B
| $272K | 0.09% |
+9,597
| New | +$261K |
|
392
Nu Holdings
NU
$70B
| $272K | 0.09% |
+19,838
| New | +$238K |
|
|
GRMN
393
Garmin
GRMN
$57.4B
| $272K | 0.09% |
+1,303
| New | +$259K |
|
394
AngioDynamics
ANGO
$610M
| $270K | 0.09% |
27,231
+7,011
| +35% | +$68.6K |
|
395
The Bancorp
TBBK
$2.7B
| $268K | 0.09% |
+4,708
| New | +$238K |
|
396
Albemarle
ALB
$13.9B
| $267K | 0.09% |
+4,262
| New | +$252K |
|
397
Lamb Weston
LW
$7.36B
| $267K | 0.09% |
5,141
-10,585
| -67% | -$567K |
|
398
DNOW Inc
DNOW
$2.51B
| $266K | 0.09% |
+17,951
| New | +$274K |
|
399
Adobe
ADBE
$98.5B
| $263K | 0.08% |
+679
| New | +$262K |
|
400
Armstrong World Industries
AWI
$7.37B
| $263K | 0.08% |
+1,616
| New | +$240K |
|
Similar funds
PC
TCM
BPIM
PA
LA
BIA
SC
SG
AXQ Capital's Q2 2025 Portfolio in Review
As of Q2 2025, AXQ Capital held 817 positions worth $310M, up 24% from $249M the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
AXQ Capital deployed $49M of net new capital in Q2 2025, opening 340 new positions and adding to 127 existing holdings. Its largest new stake was Thermo Fisher Scientific: 5,591 shares worth $2.27M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was MGIC Investment, an estimated $1.65M trimmed.
- AXQ Capital's largest Q2 2025 buy was Thermo Fisher Scientific: 5,591 shares worth $2.27M.
- AXQ Capital added most to PG&E in Q2 2025, an estimated $2.05M increase.
- AXQ Capital's biggest Q2 2025 reduction was MGIC Investment, cutting an estimated $1.65M.
- AXQ Capital fully exited NextEra Energy in Q2 2025, selling an estimated $2.51M.
- AXQ Capital's ten largest holdings make up 7.4% of its $310M portfolio in Q2 2025.
- AXQ Capital opened 340 new positions and closed 270 in Q2 2025.
- AXQ Capital's portfolio value rose 24% quarter-over-quarter to $310M.
Based on AXQ Capital's 13F filing for Q2 2025, filed 12 Aug 2025.